Search

everythinglearnresearchcommunity

for

Search:↓

Lipids from Schizochytrium sp. help prevent hair loss by protecting hair cells from damage and promoting hair growth.

The study concluded that immune cells attacking hair follicles cause hair loss in alopecia, with genetics and environment also playing a role, and highlighted the potential of certain treatments.

Baricitinib combined with other immune therapies may safely and effectively treat severe scalp hair loss.

Genetic analysis of rabbits identified key genes for traits like coat color, body size, and fertility.

The back of the scalp has more nerve fibers than the front, which may explain why some people feel more sensitivity there.

Oral tofacitinib helped regrow hair in over half of the patients with severe alopecia, but relapses and side effects were common.

Alopecia areata is an autoimmune disease causing patchy hair loss, often with other autoimmune disorders, but its exact causes are unknown.

COVID-19 might worsen symptoms and progression of benign prostatic hyperplasia, possibly due to inflammation and metabolic disturbances in the prostate gland. More research is needed to confirm this.

FLCN helps control iron levels in cells.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Stem cell niches support, regulate, and coordinate stem cell functions.

Alopecia areata involves immune system imbalances that may lead to depression and anxiety.

Stem cell niches are adaptable and key for tissue maintenance and repair.

Researchers identified genes and proteins that may influence wool thickness in sheep.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Skin aging reflects overall body aging and can indicate internal health conditions.

Women with scarring alopecia are less likely to have used hormone replacement therapy or oral contraceptives compared to those with female pattern hair loss.

New research is helping develop better treatments for alopecia areata.

Keratinocytes help heal skin wounds by interacting with immune cells and producing substances that kill pathogens.

Minoxidil is the only FDA-approved topical drug for treating male or female pattern hair loss, and other medications like finasteride and dutasteride can also increase hair growth.

A wearable device using electric stimulation can significantly improve hair growth.

The document concludes that the skin's immune system is complex, involving interactions with hair follicles, nerves, and microbes, and can protect or cause disease, offering targets for new treatments.

Regenerative pharmacology, which combines drugs with regenerative medicine, shows promise for repairing damaged body parts and needs more interdisciplinary research.

Topical tofacitinib may grow hair better than minoxidil by increasing VEGF and reducing inflammation.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Tofacitinib nanoparticles can safely and effectively treat alopecia areata by targeting hair follicles.

Advanced therapies like gene, cell, and tissue engineering show promise for hair regrowth in alopecia, but their safety and effectiveness need more verification.